The impact of the Covid-19 pandemic on R&D and commercialization of new drugs and vaccines

Intoccia, Andrea Erminio (A.A. 2019/2020) The impact of the Covid-19 pandemic on R&D and commercialization of new drugs and vaccines. Tesi di Laurea in Health care management, Luiss Guido Carli, relatore Daniele Mascia, pp. 150. [Master's Degree Thesis]

[img] PDF (Full text)
Restricted to Registered users only

Download (3MB) | Request a copy

Abstract/Index

From laboratory to patient: the journey of medicinal products. Product roadmap of medicines. Vaccine making: a complex pipeline. Making steps toward the future: how to cut decades of research and technology implementation thanks to new opportunities and challenges. Procedures questioned by the global health emergency due to the pandemic crisis: new models with high risks management are born. Impacts of Covid-19 on the pharmaceutical sector. Biopharmaceutical companies: the fight against the novel Coronavirus. Partnership and collaboration in response to Covid-19 pandemic. New strategies for biopharma: the next normal. Lesson learned from Covid-19 pandemic for a future based on innovation. Shaping the next normal.

References

Bibliografia: pp. 122-149.

Thesis Type: Master's Degree Thesis
Institution: Luiss Guido Carli
Degree Program: Master's Degree Programs > Master's Degree Program in Gestione d'impresa (LM-77)
Chair: Health care management
Thesis Supervisor: Mascia, Daniele
Thesis Co-Supervisor: Homberg, Fabian Kurt Falk
Academic Year: 2019/2020
Session: Extraordinary
Additional Information: Sessione anticipata 2020/2021.
Deposited by: Alessandro Perfetti
Date Deposited: 14 Jun 2021 07:03
Last Modified: 14 Jun 2021 07:03
URI: https://tesi.luiss.it/id/eprint/29747

Downloads

Downloads per month over past year

Repository Staff Only

View Item View Item